2,3-dinor-thromboxane b2 has been researched along with Intermittent Claudication in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Edlund, A; FitzGerald, GA; Sevastik, B; Wennmalm, A | 1 |
1 other study(ies) available for 2,3-dinor-thromboxane b2 and Intermittent Claudication
| Article | Year |
|---|---|
Excretion of thromboxane A2 and prostacyclin metabolites during treadmill exercise in patients with intermittent claudication.
Topics: 6-Ketoprostaglandin F1 alpha; Aged; Female; Humans; Intermittent Claudication; Male; Middle Aged; Physical Exertion; Thromboxane B2 | 1988 |